Acute Interstitial Pneumonia and Acute Exacerbations of Idiopathic Pulmonary Fibrosis

ABSTRACT

Acute interstitial pneumonia (AIP) and acute exacerbations of idiopathic pulmonary fibrosis (AEIPF) are similar respiratory disorders characterized by the rapid development of progressive dyspnea and cough. Both frequently lead to respiratory failure and death. Pathologically, each is characterized by the presence of a diffuse alveolar damage (DAD) pattern; in AIP, DAD is the sole pattern, whereas in AEIPF DAD is superimposed upon a background usual interstitial pneumonia. They differ in that patients with AEIPF have preexisting idiopathic pulmonary fibrosis, whereas patients with AIP have no predisposing disorders to account for their disease. Because both presentations overlap with multiple other causes of acute lung injury, a comprehensive evaluation is necessary to rule out disorders such as overwhelming infection or congestive heart failure. Although a confident diagnosis can be achieved without it, a surgical lung biopsy is necessary to provide a definitive diagnosis. Despite minimal evidence, glucocorticoids are frequently begun once microbiological evaluation confirms the absence of infection. Despite therapy, the case fatality rate ranges up to 70% for both, with most patients dying in the first 2 weeks. Survivors of the acute event can recover to their previous baseline; however, most AIP survivors will stabilize with some functional impairment, whereas in those with AEIPF, progressive fibrosis with functional deterioration is the rule.

Acute interstitial pneumonia - idiopathic interstitial pneumonia - diffuse alveolar damage - Hamman-Rich syndrome - idiopathic pulmonary fibrosis

REFERENCES

• 1 Joint Statement of the American Thoracic Society and the European Respiratory Society . International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.  Am J Respir Crit Care Med. 2002;  165 277-304
• 2 Vourlekis J S. Acute interstitial pneumonia.  Clin Chest Med. 2004;  25 739-747 , vii
• 3 Ware L B, Matthay M A. The acute respiratory distress syndrome.  N Engl J Med. 2000;  342 1334-1349
• 4 Pugin J, Verghese G, Widmer M C, Matthay M A. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.  Crit Care Med. 1999;  27 304-312
• 5 Modelska K, Pittet J F, Folkesson H G, Courtney Broaddus V, Matthay M A. Acid-induced lung injury: protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits.  Am J Respir Crit Care Med. 1999;  160 1450-1456
• 6 Sznajder J I. Strategies to increase alveolar epithelial fluid removal in the injured lung.  Am J Respir Crit Care Med. 1999;  160 1441-1442
• 7 Greene K E, Wright J R, Steinberg K P et al.. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.  Am J Respir Crit Care Med. 1999;  160 1843-1850
• 8 Matthay M A, Wiener-Kronish J. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.  Am Rev Respir Dis. 1990;  142 1250-1257
• 9 Ware L, Matthay M A. Maximal alveolar epithelial fluid clearance in clinical acute lung injury: an excellent predictor of survival and the duration of mechanical ventilation.  Am J Respir Crit Care Med. 1999;  159 A694
• 10 Pache J C, Christakos P G, Gannon D E, Mitchell J J, Low R B, Leslie K O. Myofibroblasts in diffuse alveolar damage of the lung.  Mod Pathol. 1998;  11 1064-1070
• 11 Bonaccorsi A, Cancellieri A, Chilosi M et al.. Acute interstitial pneumonia: report of a series.  Eur Respir J. 2003;  21 187-191
• 12 Ichikado K, Johkoh T, Ikezoe J et al.. Acute interstitial pneumonia: high-resolution CT findings correlated with pathology.  AJR Am J Roentgenol. 1997;  168 333-338
• 13 Ichikado K, Suga M, Muller N L et al.. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors.  Am J Respir Crit Care Med. 2002;  165 1551-1556
• 14 Johkoh T, Muller N L, Taniguchi H et al.. Acute interstitial pneumonia: thin-section CT findings in 36 patients.  Radiology. 1999;  211 859-863
• 15 Olson J, Colby T, Elliott C. Hamman-Rich syndrome revisited.  Mayo Clin Proc. 1990;  65 1538-1548
• 16 Primack S L, Hartman T E, Ikezoe J, Akira M, Sakatani M, Muller N L. Acute interstitial pneumonia: radiographic and CT findings in nine patients.  Radiology. 1993;  188 817-820
• 17 Quefatieh A, Stone C H, DiGiovine B, Toews G B, Hyzy R C. Low hospital mortality in patients with acute interstitial pneumonia.  Chest. 2003;  124 554-559
• 18 Vourlekis J S, Brown K, Cool C D et al.. Acute interstitial pneumonitis: case series and review of the literature.  Medicine (Baltimore). 2000;  79 369-378
• 19 Suh G Y, Kang E H, Chung M P et al.. Early intervention can improve clinical outcome of acute interstitial pneumonia.  Chest. 2006;  129 753-761
• 20 Bouros D, Nicholson A C, Polychronopoulos V, du Bois R M. Acute interstitial pneumonia.  Eur Respir J. 2000;  15 412-418
• 21 Tomiyama N, Muller N L, Johkoh T et al.. Acute respiratory distress syndrome and acute interstitial pneumonia: comparison of thin-section CT findings.  J Comput Assist Tomogr. 2001;  25 28-33
• 22 Travis W, Colby T, Koss M, Rosado-de-Christenson M, Muller N, King Jr T. Idiopathic interstitial pneumonia and other diffuse parenchymal lung diseases. In: King D Atlas of Nontumor Pathology: Non-neoplastic Disorders of the Lower Respiratory Tract. Washington, DC; American Registry of Pathology and the Armed Forces Institute of Pathology 2002: 49-233
• 23 Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage.  Am J Pathol. 1987;  126 171-182
• 24 Burkhardt A, Cottier H. Cellular events in alveolitis and the evolution of pulmonary fibrosis.  Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;  58 1-13
• 25 Ambrosini V, Cancellieri A, Chilosi M et al.. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series.  Eur Respir J. 2003;  22 821-826
• 26 Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases.  Chest. 1993;  103 1808-1812
• 27 Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.  AJR Am J Roentgenol. 1997;  168 79-83
• 28 Vourlekis J S, Brown K, Schwarz M I. Acute interstitial pneumonitis: current understanding regarding diagnosis, pathogenesis, and natural history.  Semin Respir Crit Care Med. 2001;  22 399-408
• 29 Yoshimura K, Nakatani T, Nakamori Y et al.. Acute exacerbation in idiopathic interstitial pneumonia.  Nihon Kyobu Shikkan Gakkai Zasshi. 1984;  22 1012-1020
• 30 Raghu G. Poor choice of primary outcome in a clinical trial of pirfenidone in patients with IPF.  Am J Respir Crit Care Med. 2005;  172 1229-1230
• 31 Martinez F J, Safrin S, Weycker D et al.. The clinical course of patients with idiopathic pulmonary fibrosis.  Ann Intern Med. 2005;  142 963-967
• 32 Azuma A, Nukiwa T, Tsuboi E et al.. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med. 2005;  171 1040-1047
• 33 Al-Hameed F M, Sharma S. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis.  Can Respir J. 2004;  11 117-122
• 34 Rice A J, Wells A U, Bouros D et al.. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study.  Am J Clin Pathol. 2003;  119 709-714
• 35 Tiitto L, Heiskanen U, Bloigu R, Paakko P, Kinnula V, Kaarteenaho-Wiik R. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia.  Chest. 2005;  128 2375-2380
• 36 Kubo H, Nakayama K, Yanai M et al.. Anticoagulant therapy for idiopathic pulmonary fibrosis.  Chest. 2005;  128 1475-1482
• 37 Dallari R, Foglia M, Paci M, Cavazza A. Acute exacerbation of idiopathic pulmonary fibrosis.  Eur Respir J. 2004;  23 792